Average Co-Inventor Count = 5.79
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (38 from 3,232 patents)
2. Tularik Limited (11 from 126 patents)
3. Medimmune Limited (5 from 541 patents)
4. Walter and Eliza Hall Institute of Medical Research (4 from 83 patents)
5. Abbott Laboratories Corporation (2 from 4,180 patents)
6. Amgen Inc. (2 from 1,981 patents)
7. Abbvie Inc. (2 from 823 patents)
8. Nerviano Medical Sciences S.r.l. (1 from 139 patents)
9. Genetech, Inc. (1 from 98 patents)
10. Medimmue Limited (1 from 1 patent)
11. Genentench, Inc. (1 from 1 patent)
12. Curis, Inc. (141 patents)
13. Spirogen Sarl (8 patents)
55 patents:
1. 11963994 - Inhibitors of IAP
2. 11692043 - Peptidomimetic compounds and antibody-drug conjugates thereof
3. 11135303 - Pyrrolobenzodiazepines and conjugates thereof
4. 11104673 - Quaternary amine compounds and antibody-drug conjugates thereof
5. 11096982 - Inhibitors of IAP
6. 11090322 - Anthracycline disulfide intermediates, antibody-drug conjugates and methods
7. 10632210 - Peptidomimetic compounds and antibody-drug conjugates thereof
8. 10576164 - Pyrrolobenzodiazepines and conjugates thereof
9. 10570192 - Anti-wall teichoic antibodies and conjugates
10. 10556895 - Quaternary amine compounds and antibody-drug conjugates thereof
11. 10544215 - 1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
12. 10533058 - Peptidomimetic compounds and antibody-drug conjugates thereof
13. 10442836 - 1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
14. 10149913 - Anthracycline disulfide intermediates, antibody-drug conjugates and methods
15. 10124069 - Peptidomimetic compounds and antibody-drug conjugates thereof